Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396730 · ClinicalTrials.gov registry record · Phase 4
Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT04396730 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 9 participants.
The verdict
NCT04396730, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how Cannabidiol (CBD) impacts the effectiveness of oral contraceptive (birth control) pills and if CBD changes the possible side effects of birth control pills when CBD and birth control pills are taken at the same time. This study explores the potential interaction between CBD and birth control pills by assessing serum levels of the contraceptive steroid hormones ethinyl estradiol and levonorgestrel in birth control pill users when they also use CBD.
Interventions
- DRUG Placebo
- DRUG Cannabidiol Oil
- DRUG Combined oral contraceptive pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2022-03-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04396730
The ClinicalTrials.gov registry entry for NCT04396730 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04396730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04396730 about?
NCT04396730 is a clinical study titled "Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction". The purpose of this study is to assess how Cannabidiol (CBD) impacts the effectiveness of oral contraceptive (birth control) pills and if CBD changes the possible side effects of birth control pills when CBD and birth control pills are taken at the same time. This study explores the potential inter...
What is the current status of trial NCT04396730?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2020-04-08. Estimated completion is 2022-03-02.
What interventions are being tested in trial NCT04396730?
The interventions under investigation include: Placebo (DRUG), Cannabidiol Oil (DRUG), Combined oral contraceptive pill (DRUG).
Who is sponsoring clinical trial NCT04396730?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.